Agile Therapeutics, Inc. (AGRX)’in fiyatı nedir?

Agile Therapeutics, Inc. (AGRX)’in fiyatı $1.51’dir

Agile Therapeutics, Inc. (AGRX)’in piyasa değeri nedir?

Agile Therapeutics, Inc. (AGRX)’in piyasa değeri $1.12M’dir.

Agile Therapeutics, Inc. (AGRX) Tedavüldeki Hisseler

Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
2026 (TTM)	6.86M	217.90%
2023	2.16M	398.99%
2022	432.22K	35,520.10%
2021	1.21K	-97.13%
2020	42.34K	71.31%
2019	24.72K	44.06%
2018	17.16K	10.90%
2017	15.47K	9.44%
2016	14.14K	28.42%
2015	11.01K	93.22%
2014	5.70K	26.21%
2013	4.51K	0.00%
2012	4.51K	0.00%

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

2026 (TTM)

6.86M

217.90%

2023

2.16M

398.99%

2022

432.22K

35,520.10%

2021

1.21K

-97.13%

2020

42.34K

71.31%

2019

24.72K

44.06%

2018

17.16K

10.90%

2017

15.47K

9.44%

2016

14.14K

28.42%

2015

11.01K

93.22%

2014

5.70K

26.21%

2013

4.51K

0.00%

2012

4.51K

0.00%

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	2.40B	34,894.97%	IN

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke